A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

NCT00024986 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

NCT01815736 ·Status: COMPLETED ·Phase: PHASE3

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

NCT00036634 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)

NCT03251144 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Botswana Tenofovir Oral HIV Prophylaxis Trial

NCT00111150 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

NCT00528957 ·Status: COMPLETED ·Phase: PHASE3

Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

NCT01687218 ·Status: COMPLETED ·Phase: PHASE2

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

NCT00592124 ·Status: COMPLETED ·Phase: PHASE2

Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents

NCT02134431 ·Status: COMPLETED

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

NCT00002379 ·Status: COMPLETED ·Phase: PHASE2

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

NCT00112047 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection

NCT02842086 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

NCT02881320 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

NCT00984971 ·Status: COMPLETED ·Phase: PHASE1

A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

NCT00002382 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents

NCT02276612 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

NCT00158821 ·Status: COMPLETED ·Phase: PHASE3

CROSSOVER STUDY OF ON-DEMAND PREP FORMULATIONS COMPARING RECTAL AND ORAL TENOFOVIR

NCT06560684 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

NCT00414518 ·Status: COMPLETED ·Phase: NA

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

NCT00002218 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

NCT01721109 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

NCT00924898 ·Status: COMPLETED ·Phase: PHASE4

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

NCT00002184 ·Status: COMPLETED ·Phase: PHASE2

Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia

NCT00078182 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients

NCT03789968 ·Status: COMPLETED